Austar Lifesciences Limited
AULSF
$0.02
-$0.05-71.43%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.96% | -64.41% | 0.59% | 142.35% | -0.48% |
| Total Depreciation and Amortization | 0.97% | -3.60% | 0.59% | -12.40% | -0.48% |
| Total Amortization of Deferred Charges | 0.98% | -9.92% | 0.61% | 6.72% | -0.50% |
| Total Other Non-Cash Items | 0.97% | 300.36% | -0.59% | -165.20% | -0.48% |
| Change in Net Operating Assets | 0.97% | -- | -- | -- | -0.48% |
| Cash from Operations | 0.97% | 141.48% | 0.59% | -51.38% | -0.48% |
| Capital Expenditure | -0.97% | -5.84% | -0.59% | 25.17% | 0.48% |
| Sale of Property, Plant, and Equipment | 1.23% | -- | -- | -- | -0.43% |
| Cash Acquisitions | -- | -- | -- | -- | -0.51% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.92% | -83.48% | 0.60% | 284.58% | -0.52% |
| Cash from Investing | -0.97% | -273.66% | -0.58% | 65.58% | 0.49% |
| Total Debt Issued | 0.00% | 47.14% | 0.00% | -2.48% | 0.00% |
| Total Debt Repaid | 0.00% | -29.22% | 0.00% | 5.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -8.43% | 0.00% | 14.63% | 0.00% |
| Cash from Financing | -0.97% | 47.90% | -0.59% | 16.62% | 0.48% |
| Foreign Exchange rate Adjustments | -0.84% | -252.48% | -1.00% | -118.15% | -0.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.97% | 3,058.95% | -0.61% | -107.90% | -0.49% |